Fresenius Medical Care AG & Co. KGaA (FMEA) — Capital Reinvestment Ratio
Fresenius Medical Care AG & Co. KGaA (FMEA) has a Capital Reinvestment Ratio of 0.84x as of March 2026, meaning it reinvests 1% of its operating cash flow (€226.89 Million) in capital expenditures (€190.07 Million). See FMEA free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Fresenius Medical Care AG & Co. KGaA Capital Reinvestment Ratio (2016–2025)
This chart tracks Fresenius Medical Care AG & Co. KGaA's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Fresenius Medical Care AG & Co. KGaA (2016–2025)
Year-by-year Capital Reinvestment Ratio for Fresenius Medical Care AG & Co. KGaA from 2016 to 2025. For live market cap and broader valuation context, see Fresenius Medical Care AG & Co. KGaA market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | €2.68 Billion | €915.37 Million | ▲ +16.5% |
| 2024 | 0.29x | €2.39 Billion | €699.36 Million | ▲ +12.5% |
| 2023 | 0.26x | €2.63 Billion | €684.60 Million | ▼ -22.0% |
| 2022 | 0.33x | €2.17 Billion | €723.99 Million | ▼ -2.7% |
| 2021 | 0.34x | €2.49 Billion | €854.36 Million | ▲ +38.1% |
| 2020 | 0.25x | €4.23 Billion | €1.05 Billion | ▼ -43.3% |
| 2019 | 0.44x | €2.57 Billion | €1.12 Billion | ▼ -14.5% |
| 2018 | 0.51x | €2.06 Billion | €1.06 Billion | ▲ +19.0% |
| 2017 | 0.43x | €2.19 Billion | €944.46 Million | ▼ -15.0% |
| 2016 | 0.51x | €1.93 Billion | €979.36 Million | — |